NASDAQ:ADMP Adamis Pharmaceuticals (ADMP) Stock Price, News & Analysis → The AI Defense Stock Set to Soar (From Behind the Markets) (Ad) Free ADMP Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$0.77▼$3.9952-Week Range N/AVolume119,800 shsAverage Volume811,695 shsMarket Capitalization$7.26 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Adamis Pharmaceuticals alerts: Email Address Ad Crypto 101 MediaMajor Elon Musk Crypto Leak RevealedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. About Adamis Pharmaceuticals Stock (NASDAQ:ADMP)Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease. Its products include SYMJEPI epinephrine injection for the emergency treatment of allergic reactions to stinging and biting insects, allergen immunotherapy, foods, drugs, diagnostic testing substances, and other allergens, as well as idiopathic or exercise-induced anaphylaxis; and ZIMHI naloxone injection for the treatment of opioid overdose. The company is headquartered in San Diego, California.Read More Ad DTICBOE shift unlocks new weekend income strategyYou might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange. You're probably wondering, “Okay… But how does that affect me?” This perk now allows everyday traders like yourself to target extra income over the weekend. Check out this training for the full story! ADMP Stock News HeadlinesNovember 8, 2023 | morningstar.comDMK Pharmaceuticals Corp DMKSeptember 7, 2023 | msn.comAdamis changes name to DMK Pharmaceuticals, ticker to DMKMarch 28, 2024 | DTI (Ad)Buy Friday, Sell Monday, No Exceptions Every week traders grind it out Monday through Friday… But neglect trading Friday to Monday… Or… “over the weekend” As one professional trader explains, trading over the weekend is one of the most forgiving strategies you can use today. It allows him to sidestep a lot of the midweek volatility. Yet, gives him the opportunity to target some of the markets biggest stock moves. Just recently, he posted a trade on Nordstrom… The trade was published at 3pm on a Friday afternoon and by Monday morning the trade more than doubled.September 7, 2023 | finance.yahoo.comAdamis Pharmaceuticals Changes Name to DMK Pharmaceuticals to Reflect New Strategic FocusAugust 21, 2023 | finanznachrichten.deAdamis Pharmaceuticals Corporation: Adamis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateAugust 21, 2023 | finance.yahoo.comAdamis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateAugust 4, 2023 | finance.yahoo.comAdamis Pharmaceuticals Announces Closing of $8.0 Million Public OfferingAugust 2, 2023 | finance.yahoo.comAdamis Pharmaceuticals Announces Pricing of $8.0 Million Public OfferingMarch 28, 2024 | DTI (Ad)Warning: this could blow your mindBuckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…August 1, 2023 | msn.comAdamis Pharmaceuticals Stock Soars To More Than Double - What's Going On?August 1, 2023 | msn.comAdamis stock soars as high as 480% amid asset sale, drug study newsJuly 28, 2023 | marketwatch.comAdamis Pharma to Fund Clinical Study with University of Leiden Opioid ExpertJuly 28, 2023 | finance.yahoo.comAdamis Pharmaceuticals to Fund ZIMHI® Clinical Study with University of Leiden Opioid ExpertJune 26, 2023 | benzinga.comAdamis Pharmaceuticals Announces NIH Grant Funding For Treatment Of Alcohol Use Disorder, Size Not DisclosedJune 26, 2023 | finance.yahoo.comAdamis Pharmaceuticals Announces NIH Grant Funding for the Treatment of Alcohol Use DisorderJune 22, 2023 | finance.yahoo.comAdamis Pharmaceuticals Participated in White House Meeting Regarding Opioid Overdose PreventionJune 4, 2023 | fool.comAdamis Pharmaceuticals (NASDAQ: ADMP)May 31, 2023 | benzinga.comAdamis Pharmaceuticals CEO Awarded $210K Worth of Stock OptionsMay 31, 2023 | benzinga.comBoard Member at Adamis Pharmaceuticals Acquires Company Stock Options Worth 25,720 SharesMay 26, 2023 | finanznachrichten.deAdamis Pharmaceuticals Corporation: Adamis Pharmaceuticals Announces Closing of the Merger with DMK PharmaceuticalsMay 25, 2023 | finance.yahoo.comAdamis Pharmaceuticals Announces Closing of the Merger with DMK PharmaceuticalsMay 21, 2023 | seekingalpha.comAdamis Pharma slips 19% on plans for reverse stock slipMay 19, 2023 | finanznachrichten.deAdamis Pharmaceuticals Corporation: Adamis Pharmaceuticals Announces Reverse Stock SplitMay 19, 2023 | finance.yahoo.comAdamis Pharmaceuticals Announces Reverse Stock SplitMay 16, 2023 | finance.yahoo.comQ1 2023 Adamis Pharmaceuticals Corp Earnings CallMay 15, 2023 | finance.yahoo.comAdamis Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate UpdateMay 8, 2023 | finance.yahoo.comAdamis Pharmaceuticals Schedules First Quarter 2023 Financial Results Conference Call and Corporate UpdateSee More Headlines Receive ADMP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Adamis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/31/2022Today3/28/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolNASDAQ:ADMP CUSIPN/A CIK887247 Webwww.adamispharmaceuticals.com Phone(858) 997-2400FaxN/AEmployees11Year Founded2006Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-26,480,000.00 Net Margins-502.73% Pretax Margin-471.80% Return on Equity-420.53% Return on Assets-256.87% Debt Debt-to-Equity RatioN/A Current Ratio0.23 Quick Ratio0.19 Sales & Book Value Annual Sales$4.76 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value($1.26) per share Price / BookN/AMiscellaneous Outstanding Shares9,360,000Free Float9,237,000Market Cap$7.26 million OptionableOptionable Beta1.27 Social Links (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. David J. Marguglio (Age 53)Co-Founder, Interim CFO. Pres & COO Comp: $526.35kDr. Ebrahim Versi M.D. (Age 70)Ph.D., CEO & Chair of the Board Ms. Jennifer C. SuskiSr. Director of MarketingMr. Eddie Wabern Glover (Age 73)Chief Exec. Officer of US Compounding Inc Mr. Robert B. Rothermel (Age 79)Consultant Key CompetitorsChina PharmaNYSE:CPHIAcer TherapeuticsNASDAQ:ACERAytu BioPharmaNASDAQ:AYTULeaflyNASDAQ:LFLYXWELLNASDAQ:XWELView All Competitors ADMP Stock Analysis - Frequently Asked Questions How were Adamis Pharmaceuticals' earnings last quarter? Adamis Pharmaceuticals Co. (NASDAQ:ADMP) issued its earnings results on Thursday, March, 31st. The specialty pharmaceutical company reported ($4.20) EPS for the quarter, missing the consensus estimate of ($2.80) by $1.40. Adamis Pharmaceuticals had a negative net margin of 502.73% and a negative trailing twelve-month return on equity of 420.53%. During the same quarter last year, the firm earned ($11.20) earnings per share. When did Adamis Pharmaceuticals' stock split? Adamis Pharmaceuticals shares reverse split before market open on Monday, May 22nd 2023. The 1-70 reverse split was announced on Monday, May 22nd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, May 22nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split. What other stocks do shareholders of Adamis Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Adamis Pharmaceuticals investors own include Trevena (TRVN), Amarin (AMRN), Sorrento Therapeutics (SRNE), Verastem (VSTM), Dynavax Technologies (DVAX), Novavax (NVAX), SCYNEXIS (SCYX), Synergy Pharmaceuticals (SGYP), Agile Therapeutics (AGRX) and OPKO Health (OPK). Who are Adamis Pharmaceuticals' major shareholders? Adamis Pharmaceuticals' stock is owned by many different institutional and retail investors. Top institutional investors include Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include David C Benedicto, David J Marguglio, Dennis J Phd Carlo and Ronald B Moss. View institutional ownership trends. This page (NASDAQ:ADMP) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe 3rd Revolution in WarfareWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adamis Pharmaceuticals Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.